ClinConnect ClinConnect Logo
Search / Trial NCT06386770

Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block

Launched by ASWAN UNIVERSITY · Apr 24, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Bupivacaine Kidney Exploration Surgery

ClinConnect Summary

This clinical trial is studying how well dexmedetomidine, a medication that helps with pain relief, works when given in two different ways during kidney surgeries. Researchers want to find out if giving it locally (right where the pain is) or systemically (through the bloodstream) alongside another pain medication called bupivacaine will provide better pain relief for patients undergoing kidney exploration surgeries.

To participate in this trial, individuals should be between 18 and 80 years old and be scheduled for kidney surgery. They should also be in good health, with a body mass index (BMI) under 35, and not have any serious health issues. However, those who are pregnant, have a history of drug or alcohol problems, or are receiving strong pain medications before the surgery won't be eligible. Participants in the study can expect to receive either local or systemic dexmedetomidine and will be monitored for their pain relief during and after the surgery. This trial is currently looking for volunteers to help researchers understand the best way to manage pain in these types of surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • •. kidney exploration surgeries.
  • ASA I/II patients.
  • BMI \<35
  • Exclusion Criteria:
  • Getting opioid analgesics prior to surgery.
  • Local infections at the site where needle for block is to be inserted.
  • ASAIII/IV.
  • Pregnancy.
  • History of drug addiction or alcohol abuse or a psychiatric illness,

About Aswan University

Aswan University, a leading institution in Egypt, is dedicated to advancing medical research and clinical trials aimed at improving healthcare outcomes. With a strong focus on innovation and collaboration, the university harnesses its diverse expertise and state-of-the-art facilities to conduct rigorous scientific studies. By fostering partnerships with healthcare professionals and researchers, Aswan University aims to contribute valuable insights into various medical fields, ultimately enhancing patient care and public health initiatives. The university is committed to upholding the highest ethical standards in research, ensuring that all clinical trials are conducted with integrity and respect for participant welfare.

Locations

Aswan, , Egypt

Patients applied

0 patients applied

Trial Officials

Rehab A Mahmoud, MSc

Study Chair

Aswan University

Ayman M Eldemrdash

Principal Investigator

Aswan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported